Hologic Presents: Key Success Factors in Reporting Under PAMA
Critical Insights for Clinical Laboratories
- Presentation Slides (Updated January 2020)
- PAMA Resources
- Checklist: Am I an Applicable Laboratory?
- Checklist: Am I Ready to Report Applicable Information?
- PAMA Code List
- Webinar Recording
- To view a recording of the December 6, 2019 program please click the above link.
- Please note: if you have previously registered you will be prompted to enter that same e-mail address. If you have not previously registered, you will first need to complete the registration section and then you will be able to view the recorded program.
The Protecting Access to Medicare Act of 2014 (PAMA) significantly overhauled the existing Medicare Clinical Laboratory Fee Schedule (CLFS), establishing new payment rates for diagnostic tests paid on this fee schedule. CMS will soon begin the process of receiving commercial payer payment rates during the second round of PAMA data reporting beginning January 1, 2020.
CLFS reimbursement for years 2021 – 2023 will be determined based on the weighted median payment calculated from applicable laboratory (including hospital outreach laboratories) submissions of private payer payment data. It is critical that all providers submitting payment information to CMS under PAMA know the rules and resources to comply with CMS requirements. This webinar will help you determine what data must be reported, how to navigate the CMS data reporting portal and the timeline required to complete applicable information submissions. Please join us for this important informational webinar hosted by nationally recognized McDermott+Consulting speakers Dr. Paul Radensky and Deborah Godes.
December 4 2:00-3:00 ET / 11:00-12:00 PT
December 11 4:00-5:00 ET / 1:00-2:00 PT
December 12 2:00-3:00 ET / 11:00-12:00 PT
December 18 12:00-1:00 ET / 9:00-10:00 PT
December 19 11:00-12:00 ET / 8:00-9:00 PT
Register for any of the above programs here.
McDermott+Consulting’s webinar will:
- Outline PAMA rules and “applicable entities” that are required to report private payer data to CMS.
- Highlight data reporting requirements, the submission process, and when to report.
- Review CMS resources to help your lab understand the submission process.
- Q & A with the McDermott+Consulting team.
Paul Radensky, M.D., J.D., Principal
Paul Radensky, a Medicare authority board-certified in internal medicine, advises clinical laboratories and manufacturers in the diagnostics industry on reimbursement and regulatory strategies pertaining to Medicare, Medicaid and third party payors. Dr. Radensky is a recognized authority on the full range of legal, regulatory and reimbursement issues affecting the clinical laboratory industry and has substantial experience with the implementation of the PAMA legislation.
Deborah Godes, Senior Director
Deborah Godes advises clients on reimbursement and policy strategy for medical devices, diagnostics, health services, and biologics with public and private payers, including Centers for Medicare and Medicaid and managed care organizations. She has over twenty years of experience providing strategic, operational and policy consultative services to companies across the healthcare continuum as well as Fortune 100 companies. Deborah offers clients the ability to analyze and manipulate reimbursement databases to buttress data-oriented policy positions.